Mywallst WallSt.net WallSt TV WallSt Radio
fidel's Blogs
Apr
23
Posted: 7 month(s) and 15 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: fidel
This Biotech company is awaiting an positive approval for new infant drug. The FDA ruling is due on May 1st, a run up in the stock price has already begun. And upon approval the stock should pop at least 50%. Check it out. Looks like another winner. Frank in Alabama
   Add Comment / Rating
Apr
18
Posted: 7 month(s) and 21 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: fidel
It got some good news yesterday and is moving with increased volume.
   Add Comment / Rating
Apr
18
Posted: 7 month(s) and 21 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: fidel
Its' a BUY>
   Add Comment / Rating
Apr
18
Posted: 7 month(s) and 21 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: fidel
Good entry point,they are both a BUY>
   Add Comment / Rating
Apr
12
Posted: 7 month(s) and 26 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: fidel

This small biopharma company was just given the nod by FDA to submit a New Drug Application for formal approval. Successfully obtaining the necessary Phase III trial results in order to do so. They are bringing a new bug resistant antibiotic to the market. Cethromycin has been shown to treat Community aquired Pneumonia, Strep, and MRSA. Older antibiotics have quit working effectively against these bugs,MRSA is killing people left and right in our nations hospital,MRSA in case you are not aware is a bug that has developed in most the hospitals where you go in to have your tonsils removed and catch MRSA and die because very few of the current medicines are any longer effectice against these viral infections. There is a huge market for this. I listened to there Conference call this week,there were half a dozen analysts there asking many critical questions of the drugs developer Dr Flavin. They stated that they expected the NDA to approved in 3Q sometime. A number of large bio companies are currently in talks with ADLS to partner up and help bring the drug to market, and to distibute it.. Once a partner is chosen in the next 30 to 60 days,the stock price will rise to about $4.00.Based on the BV of CETH when brought to market the price is expected to rise up to the $8.00 to $10 dollars range. $4.00 dollars is the current target price that the Lazard Analyst just set on Tuesday with his udgrade of ADLS to a BUY. PPS is currently at $1.23 , I own this stock realtime @ .89 cents. 

This an excellent investment opportunity with very little downleg risks and an excellent short, near and long term potential. I expect the stock to go up to $at least $2.00 this week with the publication of the recent Upgrade by Lazard.

   Add Comment / Rating
Apr
07
Posted: 8 month(s) and 2 days(s) ago   |   1 Comment(s)   |   Rating: 0 0
Posted by: fidel

This pharma company is looking at long terms gains due to the Gov'ts bioterrorism program for smallpox. Just the first leg of the contract when implemented soon will be $100 million. Do your due diligence,but this is set for short ,near,and long term upward movement.Disclosure: I own this stock,as well as ADLS also.

Fidel in Dixie


   Add Comment / Rating
Apr
05
Posted: 8 month(s) and 4 days(s) ago   |   0 Comment(s)   |   Rating: 0 0
Posted by: fidel

Medical supplies company with a 52week high of $2.00 bucks,coming off 52 week low of .16 cents. Think of this as a lottery ticket,NOT an investment. It went up 35% Friday on 20 times the usual volume. Chart is trending up big time. Very possibly could double or quadruple your money. Or lose it all! But based on the volume someone knows something. It's definitely worth a look!

Fidel

   Add Comment / Rating